Many Drugs Being Looked at for Multiple Myeloma CD38 and Venetoclax
Martina A. Sersch, MD, Executive Medical Director at Amgen Inc., talks about Many Drugs Being Looked at for Multiple Myeloma CD38 and Venetoclax at ASCO 2018
Author: Annual-Meeting
Added: 06/05/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Myeloma